<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

1 min read

Biologics Manufacturing Asia 2023

Biologics Manufacturing Asia 2023

Date: March 15 - 16, 2023

Location: Sands Expo & Convention Center, Marina Bay Sands, Singapore - Directions

Booth: #46

Event Website: https://imapac.com/biologics-manufacturing-asia/


Join us for our live presentationS!

  • Jun Takami, the General Manager of the Chiba, Japan AGC Biologics site, will be presenting: Best Practices from a Global CDMO: How to deliver projects successfully for Global Clinical and Commercial Supply at 14:50 on March 15.
  • Luca Alberici, the General Manager of the Milan, Italy AGC Biologics site, will be presenting: Designing Flexible Capabilities and Capacities in a Complex Cell Therapy Market at 11:25 on March 16.

Click the link above to get all the details. 



You can also reach out directly to our experts attending the show

Jun Takami
General Manager, Site Head – Chiba

Email  me

Luca Alberici
General Manager, Site Head - Milan
Email  me
Kang Liu
Director, Business Development
Email me
Shigeru Kunii
Senior Director, Business Development
Email me
Giuliana Vallanti
Director, Development & Global R&D C&G, Quality Control

Email me

Learn about our cell and gene therapy services 

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Learn more about our overall cell therapy offering 

Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Discover more about our viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Learn more about our Plasmid offering

Fill out the form below to request a meeting during the event


ESGCT 30th Annual Congress, October 24-27

ESGCT 30th Annual Congress, October 24-27

CPHI Barcelona, October 24-26

CPHI Barcelona, October 24-26

BioJapan, October 11-13

BioJapan, October 11-13